Jobs / United States / Pfizer INC
Vice President, US Market Access Lead - Specialty Care
Pfizer INC · 🇺🇸 United States - New York - New York City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
Role Summary This role serves as the single point of accountability between USMAPPS and the Specialty Care Business Unit, owning access strategy, payer marketing, and brand-level contracting and pricing strategy across the full Specialty Care portfolio. The role drives and owns outcomes, integrating all USMAPPS capabilities into one coherent access plan that directly supports the Specialty Care BU President and franchise leads. The VP is expected to operate at full strategic weight, lead a team aligned to Specialty Care brands and franchise clusters, and be the single person the Specialty Care BU holds accountable for market access results. The Vice President US Market Access Lead – Specialty Care reports directly to the Senior Vice President of US Market Access & Pfizer Patient Services (USMAPPS) with a dotted line to the Specialty Care BU President. This position requires close partnership with the Specialty Care BU President, franchise leads, Strategic Contracting & Analytics, Strategic Account Management, the Patient Services, and USMAPPS leadership. The role sits on the Specialty Care BU leadership team and on the USMAPPS Leadership Team. Role Responsibilities 1. Specialty Care Access Strategy Ownership • Develop and maintain a fully integrated brand market access plan for all Specialty Care brands, covering payer marketing, contracting strategy, and pricing strategy in one coherent plan • Translate portfolio-level access priorities into brand-specific execution plans, ensuring consistency across franchise teams and alignment with enterprise GTN objectives • Define payer value propositions, messaging, and positioning for Specialty Care brands in partnership with access marketing resources • Ensure brand-level pricing and contracting strategies optimize net trade sales and gross-to-net outcomes across payer, GPO, and channel • Define and monitor access performance metrics at the brand and portfolio level, including access quality, access speed, GTN performance, and launch readiness • Ensure LOE assets receive efficient, right-sized access support while growth and launch assets receive differentiated, higher-touch engagement models • Periodically reassess and reallocate brand-level resources across the Specialty Care portfolio based on lifecycle stage, launch timing, and business priority • Proactively adjust access plans in response to external environment shifts, including IRA drug pricing dynamics, 340B evolution, PBM-payer consolidation, and formulary changes 2. BU Partnership & Representation • Serve as the single point of communication and accountability between USMAPPS and the Specialty Care BU President and franchise leads for all access, contracting strategy, and payer marketing needs • Sit on the Specialty Care BU leadership team as primary USMAPPS advisor to franchise leads, operating as a strategic partner rather than a transactional interface • Represent Specialty Care BU access needs back into USMAPPS leadership, escalating resource gaps, strategic misalignment, or unresolved cross-functional tensions • Partner with Specialty Care BU franchise leads to understand brand P&L objectives and translate these into specific access, contracting, and payer marketing priorities • Flag trade-offs between revenue maximization and GTN discipline to BU and USMAPPS leadership, ensuring enterprise-level decision-making rather than brand-pressure-driven discounting • Proactively socialize USMAPPS access capabilities and strategic intent with Specialty Care BU leadership to build trust and reduce friction at the interface • Drive a cultural reset within the BU interface toward proactive cross-functional collaboration